Alkem Labs Gets EIR From US FDA For Baddi Facility
Drug firm Alkem Laboratories announced that the United States Food and Drug Administration (FDA) has issued an establishment inspection report (EIR) for its manufacturing facility at Baddi in Himachal Pradesh.US FDA inspected Baddi facility from February 17 to 21, 2020, Alkem Laboratories said in a BSE filing.The company said that the inspection has now been closed by the US FDA.Alkem Laboratories is a multinational pharmaceutical company headquartered in Mumbai, Maharashtra that manufactures and sells pharmaceutical generics, formulations and neutraceutricals in India. Alkem has 21 manufacturing facilities: 19 in India and 2 in the US. The company had set up its research and development facility for ANDA development at Taloja in 2003.
Let’s apply Data-Driven Pricing to Your APIs
Sick and tired of always wondering if you are being asked to pay the right price for your APIs? This empowers you with the answers you need to make the right decisions in the Global API market.
Chemxpert Database is one of the biggest and most comprehensive directories of pharma and chemicals, manufacturers, suppliers and information. Provided with current information on prices, demand and transactions, it gives you instant feedback on whether you are buying what is right and at the right time.
Start using market intelligence today and allow yourself to be in control in the API market.
Check it out today and make more informed sourcing decisions!
Learn More!